XERACALM AD

Eczema

Replenishing balm

XERACALM AD Replenishing balm has been specially formulated to meet the needs of very dry skin with an atopic tendency. Thanks to its patented biotechnological active ingredient I-Modulia, optimized by the Dextrabiome, it directly targets the virulence factors of Staphylococcus aureus at the heart of the skin microbiome.

This skin care product immediately soothes itching, reduces the frequency of intense dryness flare-ups and offers prolonged efficacy for at least 6 months¹.
It nourishes the skin for 48 hours² and penetrates quickly, leaving no greasy film.

Two alternative textures are available, offering the same triple efficacy:
IMMEDIATE SOOTHING - ANTI-DRYNESS - ANTI-RELAPSE: Cream and Milky Gel

Terms of use

¹Clinical research under dermatological and pediatric control, 2 applications per day for 6 months, 65 subjects, no relapse for 98% of patients, limits the risk of recurrence of intense dryness flare-ups.

²Instrumental test, 2 applications / day for 7 days, 20 subjects

AV_XERACALM_A.D_2026_Replenishing-Balm_Packshot_front_400ml_3282770399523

av_xeracalm-ad_replenishing-balm_3282770399523_still-life-product_16-9

New

For whom?

From 1 year old

Children

Adults
Price

400mL

200mL
Texture

-Balm texture

- Penetrates quickly without leaving a greasy film

Patient relations

Application tips

1- Cleanse skin with Xeracalm A.D lipid replenishing oil

2 - Nourish with Xeracalm A.D Replenishing balm for 48 hours of nourishment and a triple action: immediate soothing, anti-itching, anti-relapse.

3 - Immediately soothe intense itching with Xeracalm A.D Soothing Concentrate, to take anywhere.
In combination with the following treatments

Proven tolerance in association with atopic dermatitis and oncology treatments.

Patient information sheets

To support your patients during their treatments

How to care daily for your atopic skin?

Prescriptions

To save time on your medical prescriptions in combination with dermo-cosmetic care routines

Adult atopic dermatitis Atopic dermatitis in babies and children

XERACALM AD

Replenishing balm

Patient relations
Technology of action
Ingredients
Clinical results and publications

I-MODULIA+ acts specifically on the virulence of S.AUREUS

Staphylococcus aureus est un pathogène opportuniste qui peut faire partie du microbiome cutané en tant que commensal. Dans certaines conditions, il peut adopter un comportement virulent et sécréter des facteurs de virulence capables de perturber l’intégrité de l’épiderme, d’activer le système immunitaire et d’exacerber l’inflammation cutanée.

I-Modulia+ acts directly on the main virulence factors produced by Staphylococcus aureus, helping to reduce its inflammatory potential. By targeting these molecular triggers, it promotes the bacterium's return to a commensal state, where it coexists harmlessly with the skin microbiome.

Ingredients

Active ingredients:

I-MODULIA+

I-MODULIA+ embodies the evolution of our multi-competent postbiotic active ingredient.

Find out more

LIPID:B2

The most effective nutrient complex identified in over 20,000 models¹. Provides the lipids essential to the proper functioning of the skin barrier and reinforces it.

Find out more

Formula details:

AVENE THERMAL SPRING WATER (AVENE AQUA)

CAPRYLIC/CAPRIC TRIGLYCERIDE

GLYCERIN

CARTHAMUS TINCTORIUS (SAFFLOWER) SEED OIL

CETEARYL ALCOHOL

AQUAPHILUS DOLOMIAE EXTRACT

MALTODEXTRIN

CETEARYL GLUCOSIDE

POLYACRYLATE-13

GLYCERYL STEARATE

PEG-100 STEARATE

SODIUM DEXTRAN SULFATE

OLETH-10

CETYL ALCOHOL

SODIUM CITRATE

POLYISOBUTENE

BROUSSONETIA PAPYRIFERA STEM EXTRACT

CITRIC ACID

POLYSORBATE 20

ARGININE

SORBITAN ISOSTEARATE

WATER

TOCOPHEROL

HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL

Click on an ingredient type to highlight it in the list

Active ingredient

Nourisher

Moisturizer

Emulsifier

Stabilizing agent

Texturing agent

Solubilizer

PH regulator

Solvent

Clinical results and publications

Links to clinical results

Tolerance and efficacy of XeraCalm AD balsam in subjects with atopic dermatitis

View all clinical results

Links to Publications

The combination of dextran sulfate sodium and the bioactive agent I-modulia® attenuates the expression of Staphylococcus aureus virulence and δ-toxin production.

View all publications

Efficacy results

-50%

SCORAD IN ONE MONTH¹

FLARE-UP FOR 6 MONTHS²

2x LESS

ITCHING FROM 1 WEEK³

2x LESS

DRYNESS FROM 1 WEEK³

Legal notes

¹Clinical scoring (SCORAD) under dermatological and pediatric control, 65 subjects, twice-daily application for 6 months, body and face.

²Clinical scoring, 2 applications per day for 6 months, 65 subjects, no relapse for 88% of patients, limits the risk of repeated severe dryness flare-ups.

³Clinical scoring (SCORAD) under dermatological and pediatric control, 65 subjects, twice-daily application for 6 months, body and face.